SCHEMBL23818745

SCHEMBL23818745

C[C@H](N[PH](=O)OC[C@]1(C#N)CC[C@H](c2ccc3c(N)ncnn23)O1)C(=O)OC1CCN(C)CC1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.30
▸ JAK1 P23458 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23818901 0.88 POLRMT (0.30) —
SCHEMBL23819156 0.88 AXL (0.32) —
SCHEMBL23818809 0.87 AXL (0.31) —
SCHEMBL23818848 0.86 AXL (0.30) —
SCHEMBL23818829 0.86 AXL (0.30) JAK2JAK1
SCHEMBL23818779 0.83 POLRMT (0.32) JAK2JAK1
SCHEMBL23818539 0.80 POLRMT (0.34) —
SCHEMBL26237826 0.79 POLRMT (0.35) —
SCHEMBL23819232 0.79 POLRMT (0.33) —
SCHEMBL26237462 0.78 POLRMT (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210284670-A1 ANTIVIRAL COMPOUNDS MAVS, HAVCR2, ZC3HAV1 JAK2 2606/4885JAK1 4312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback